The impact of HVH-2930 and 5b on HSP90 PTMs and CHIP/HOP occupancy in these two molecules was not reported. However, targeting the CTD of HSP90 could shift CHIP- and HOP-binding dynamics and cancer progression. This evidence concerns the gene HSP90AA1 and cancer.